2010 BC Guide in Determining Fitness to Drive

11.7 Private and commercial drivers with Type 2 diabetes that is treated with insulinsecretagogues .................................................................................................................. 9111.8 Private drivers with diabetes treated with insulin .................................................... 9311.9 Commercial drivers with diabetes treated with insulin ........................................... 9511.10 Private drivers who have an episode of severe hypoglycemia ................................ 9811.11 Private drivers who have an episode of hypoglycemia unawareness................... 10011.12 Private drivers who have persistent hypoglycemia unawareness ........................ 10111.13 Commercial drivers who have an episode of severe hypoglycemia ..................... 10311.14 Commercial drivers who have an episode of hypoglycemia unawareness.......... 10511.15 Commercial drivers who have persistent hypoglycemia unawareness ............... 10711.16 Doctor’s report on commercial driver with diabetes on insulin ........................... 10811.17 Driver’s report – commercial driver with diabetes on insulin ............................. 110Chapter 12: Peripheral Vascular Diseases ............................................................................. 112BACKGROUND ......................................................................................................................... 11212.1 About peripheral vascular diseases ........................................................................... 11212.2 Prevalence and incidence of peripheral vascular diseases .................................... 11312.3 Peripheral vascular diseases and adverse driving outcomes ................................ 11412.4 Effect of peripheral vascular diseases on functional ability to drive ................... 11412.5 Compensation ............................................................................................................... 116GUIDELINES ............................................................................................................................. 11712.6 Private and commercial drivers with peripheral arterial disease ........................ 11712.7 Private drivers who have an aneurysm or dissection ............................................. 11912.8 Private and commercial drivers who have had surgery for an aneurysm ordissection ....................................................................................................................... 12012.9 Commercial drivers who have an aneurysm or dissection .................................... 12112.10 Private and commercial drivers who have deep-vein thrombosis........................ 122Chapter 13: Musculoskeletal Conditions................................................................................ 123BACKGROUND ......................................................................................................................... 12313.1 About musculoskeletal conditions ............................................................................. 12313.2 Prevalence and incidence of musculoskeletal conditions ....................................... 12313.3 Musculoskeletal conditions and adverse driving outcomes ................................... 12413.4 Effect of musculoskeletal conditions on functional ability to drive ..................... 12413.5 Compensation ............................................................................................................... 125GUIDELINES ............................................................................................................................. 12713.6 Private and commercial drivers who have lost a limb ........................................... 12713.7 Private and commercial drivers who have a chronic musculoskeletal condition......................................................................................................................................... 128Chapter 14: Chronic Renal Disease......................................................................................... 130BACKGROUND ......................................................................................................................... 13014.1 About chronic renal disease ....................................................................................... 13014.2 Prevalence and incidence of chronic renal disease ................................................. 13014.3 Chronic renal disease and adverse driving outcomes ............................................ 13114.4 Effect of chronic renal disease on functional ability to drive ................................ 13114.5 Compensation ............................................................................................................... 132GUIDELINES ............................................................................................................................. 13314.6 Private and commercial drivers with stage 1 or 2 renal disease .......................... 133vi